Actively Recruiting
Study to Assess Safety and Effectiveness of Autologous BonoFill-II for Bone Regeneration and Healing in Long and Short Bone Fractures and Defects
Led by BonusBio Group Ltd · Updated on 2025-12-10
40
Participants Needed
6
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
This trial investigates the safety and effectiveness of BonoFill-II, an autologous bone-regenerating graft, for repairing deficient bone in adults with certain types of bone fractures and defects. It focuses on two clinical conditions extra-articular comminuted fractures in long and short bones, and extra or intra-articular bone gaps or non-unions that cannot heal on their own. Participants will undergo a surgical procedure where BonoFill-II is transplanted into the affected bone site, followed by fracture fixation using plates, screws, intramedullary nails, or external fixators as needed. The surgery is performed under local or general anesthesia. External fixators may be removed once bone healing is satisfactory. Blood, urine, X-rays, and CT scans are used to monitor safety and healing progress. Throughout the 12-month follow-up, researchers will assess safety by checking for abnormal bone growth or site abnormalities, and effectiveness by evaluating bone continuity via CT scans and weight-bearing ability at 3, 6, and 12 months. Various blood tests and serology screenings will also be performed. The study lasts for up to 12 months after the intervention to carefully observe healing and any safety concerns.
CONDITIONS
Brief Title
Enhancement of Bone Regeneration and Healing in the Extremities by the Use of Autologous BonoFill-II
Research Team
N
Nimrod Rozen, MD, PhD
V
Vered Kivity, PhD, MBA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here